Insider Transactions Reported by 15 Insiders of Tempest Therapeutics, Inc.

Symbol
TPST on Nasdaq
Location
Brisbane, CA

There are no Buy or Sell transactions made by insiders since 05 Jan 2025

Tempest Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Versant Vantage II, L.P. 10%+ Owner $10,127,118 29 Apr 2022
Versant Venture Capital VI, L.P. 10%+ Owner $2,562,608 08 Aug 2024
Rock Springs Capital Management LP 10%+ Owner $352,066 30 Dec 2021
Stephen R. Brady President and CEO, Director $97,853 02 Jan 2025
Justin Trojanowski Corporate Controller $47,883 02 Jan 2025
Samuel Whiting Chief Medical Officer $20,390 02 Jan 2025
Nicholas Maestas Chief Financial Officer 02 Jan 2025
Pierre Lorenzo Corporate Controller 21 Jun 2022
Thomas W. Dubensky President, Director 03 Jan 2023
Christine Pellizzari Director 13 Jun 2024
MICHAEL RAAB Director 13 Jun 2024
GEOFFREY NICHOL Director 13 Jun 2024
Ronit Simantov Director 13 Jun 2024
Thomas Woiwode Director 17 Jun 2022
Stella Xu Director 01 Jul 2021

Recent Insider Transactions by Companies or Individuals for Tempest Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.